Diagnostic Accuracy of HPV Circulating Tumor DNA Following Non‐Diagnostic FNA of a Cystic Lateral Neck Mass
Open Access
- 7 October 2025
- journal article
- Published by Wiley in Head & Neck
- Vol. 48 (2) , 543-548
Abstract
Background: Cystic lateral neck masses in adults commonly represent nodal metastases from HPV‐associated oropharyngeal squamous cell carcinoma (OPSCC) or benign lesions. Because cystic lesions are relatively acellular, fine‐needle aspiration (FNA) is often non‐diagnostic. HPV circulating tumor DNA (ct‐DNA) may aid diagnosis in these cases. Methods: We conducted a two‐institution retrospective review of patients with cystic neck masses and non‐diagnostic FNA who underwent pre‐treatment HPV ct‐DNA testing. Sensitivity, specificity, and predictive values were calculated based on final pathology. Results: Thirty‐two patients were included. HPV ct‐DNA was positive in 20/32 (62.5%) cases, all of which were HPV‐associated OPSCC. Four patients with negative HPV ct‐DNA were ultimately diagnosed with HPV‐associated OPSCC (sensitivity: 83%, specificity: 100%, PPV: 100%, NPV: 67%). Conclusion: HPV ct‐DNA demonstrated high specificity and may complement standard workup in adult cystic neck masses with non‐diagnostic FNA. Positive HPV ct‐DNA results should prompt further evaluation for HPV‐associated OPSCC.Keywords
Funding Information
- National Cancer Institute (1K08CA293255‐0)
This publication has 27 references indexed in Scilit:
- Pretreatment Liquid Biopsy and Clinicopathologic Features in HPV−Associated Oropharyngeal Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2025
- Diagnostic Accuracy of Circulating Tumor HPV DNA Testing in Patients With a Lateral Neck MassJAMA Otolaryngology–Head & Neck Surgery, 2024
- Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell DiseaseJAMA Otolaryngology–Head & Neck Surgery, 2024
- Association of Core Biopsy With Extranodal Extension in Surgically Treated Human Papillomavirus–Associated Oropharyngeal Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2023
- Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus–Associated Oropharyngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2023
- It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: Systematic review and meta‐analysisHead & Neck, 2023
- Blood and saliva‐derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus‐associated head and neck cancerCancer Medicine, 2023
- Novel HPV Associated Oropharyngeal Squamous Cell Carcinoma Surveillance DNA Assay Cost AnalysisThe Laryngoscope, 2023
- Association of Pretreatment Circulating Tumor Tissue–Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2022
- Staging of human papilloma virus related cancers of the oropharynxJournal of Surgical Oncology, 2021